Brinzolamide is used in the pharmaceutical industry for the formulation and manufacture of anti-glaucoma eye drop preparations.

The main purpose of brinzolamide as a raw material is to provide the therapeutic activity required to reduce intraocular pressure in ophthalmic medicines used for glaucoma and ocular hypertension treatment.

Brinzolamide is a active pharmaceutical ingredient (API) in ophthalmic formulations. It appears as a white to off-white powder and functions as a carbonic anhydrase inhibitor.